Cost-effectiveness finding of RAS testing for corresponding targeted therapies.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
Costs by procedure and calculation of the total price of each variety of treatment found in the pres...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $6...
Cost-effectiveness finding of KRAS testing for corresponding targeted therapies.</p
Results of the main cost-effectiveness analysis of three different DAA treatment scenarios.</p
<p>Cost-effectiveness plane presenting all non-dominated and selected dominated screening protocols ...
<p>Cost-effectiveness analysis results for complete case and sensitivity analyses.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
<p>Results of the cost effectiveness analysis according to incremental cost effectiveness ratio (ICE...
<p>Results of base case cost-effectiveness analysis of test strategies for diagnosis of MD.</p
Despite the increasing number of potential biomarkers identified in laboratories and reported in muc...
Despite the increasing number of potential biomarkers identified in laboratories and reported in muc...
<p>One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
Cost-effectiveness plane in incremental number of treatment success and incremental cost.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
Costs by procedure and calculation of the total price of each variety of treatment found in the pres...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $6...
Cost-effectiveness finding of KRAS testing for corresponding targeted therapies.</p
Results of the main cost-effectiveness analysis of three different DAA treatment scenarios.</p
<p>Cost-effectiveness plane presenting all non-dominated and selected dominated screening protocols ...
<p>Cost-effectiveness analysis results for complete case and sensitivity analyses.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen screening with tre...
<p>Results of the cost effectiveness analysis according to incremental cost effectiveness ratio (ICE...
<p>Results of base case cost-effectiveness analysis of test strategies for diagnosis of MD.</p
Despite the increasing number of potential biomarkers identified in laboratories and reported in muc...
Despite the increasing number of potential biomarkers identified in laboratories and reported in muc...
<p>One-way sensitivity analyses of cost-effectiveness for different anemia treatment targets.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 15%....
Cost-effectiveness plane in incremental number of treatment success and incremental cost.</p
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen prevalence of 5%.<...
Costs by procedure and calculation of the total price of each variety of treatment found in the pres...
Sensitivity analysis results evaluating cost-effectiveness of Histoplasma antigen testing cost of $6...
DOI
Add to ORKG